| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exosomes | 27 | 2024 | 253 | 12.220 |
Why?
|
| Collagen Type IV | 53 | 2024 | 108 | 8.730 |
Why?
|
| Collagen | 65 | 2023 | 752 | 4.660 |
Why?
|
| Fibroblasts | 34 | 2023 | 1682 | 4.560 |
Why?
|
| Fibrosis | 47 | 2020 | 793 | 4.530 |
Why?
|
| Mesoderm | 21 | 2015 | 404 | 4.420 |
Why?
|
| Autoantigens | 42 | 2014 | 234 | 4.380 |
Why?
|
| Nephritis, Hereditary | 23 | 2024 | 47 | 4.000 |
Why?
|
| Basement Membrane | 48 | 2023 | 138 | 3.780 |
Why?
|
| Neovascularization, Pathologic | 33 | 2018 | 1547 | 3.750 |
Why?
|
| Angiogenesis Inhibitors | 27 | 2014 | 1248 | 3.490 |
Why?
|
| Kidney Diseases | 20 | 2020 | 691 | 3.300 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 31 | 2010 | 40 | 3.170 |
Why?
|
| Endothelial Cells | 22 | 2023 | 1048 | 3.090 |
Why?
|
| Extracellular Matrix | 26 | 2021 | 554 | 3.050 |
Why?
|
| Kidney Glomerulus | 32 | 2007 | 156 | 3.010 |
Why?
|
| Cancer-Associated Fibroblasts | 8 | 2023 | 107 | 2.980 |
Why?
|
| Kidney | 45 | 2021 | 2146 | 2.910 |
Why?
|
| Collagen Type I | 10 | 2022 | 204 | 2.870 |
Why?
|
| Pancreatic Neoplasms | 24 | 2023 | 5061 | 2.870 |
Why?
|
| Animals | 243 | 2024 | 59536 | 2.810 |
Why?
|
| Neoplasms | 50 | 2024 | 15193 | 2.800 |
Why?
|
| Tumor Microenvironment | 22 | 2023 | 2864 | 2.600 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 12 | 2023 | 1331 | 2.570 |
Why?
|
| Epithelial-Mesenchymal Transition | 15 | 2021 | 973 | 2.530 |
Why?
|
| Transforming Growth Factor beta | 31 | 2017 | 1130 | 2.360 |
Why?
|
| Myofibroblasts | 5 | 2022 | 133 | 2.330 |
Why?
|
| Neovascularization, Physiologic | 12 | 2014 | 345 | 2.300 |
Why?
|
| Extracellular Vesicles | 4 | 2023 | 135 | 2.280 |
Why?
|
| Bone Morphogenetic Proteins | 14 | 2013 | 268 | 2.180 |
Why?
|
| Mice | 141 | 2024 | 34495 | 2.150 |
Why?
|
| Carcinoma, Pancreatic Ductal | 11 | 2023 | 1724 | 2.140 |
Why?
|
| Epithelial Cells | 24 | 2021 | 1818 | 2.000 |
Why?
|
| Pre-Eclampsia | 8 | 2020 | 212 | 1.990 |
Why?
|
| Cell Communication | 8 | 2023 | 509 | 1.920 |
Why?
|
| Endothelium | 8 | 2018 | 158 | 1.820 |
Why?
|
| Bone Morphogenetic Protein 7 | 17 | 2018 | 63 | 1.600 |
Why?
|
| Signal Transduction | 38 | 2021 | 11965 | 1.570 |
Why?
|
| Stromal Cells | 8 | 2020 | 825 | 1.520 |
Why?
|
| Podocytes | 7 | 2024 | 120 | 1.510 |
Why?
|
| RNA, Small Interfering | 9 | 2023 | 2216 | 1.500 |
Why?
|
| Endostatins | 13 | 2011 | 48 | 1.500 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2023 | 1586 | 1.380 |
Why?
|
| Endothelium, Vascular | 19 | 2020 | 891 | 1.370 |
Why?
|
| Autoantibodies | 20 | 2005 | 576 | 1.370 |
Why?
|
| Neoplasm Metastasis | 20 | 2021 | 5112 | 1.370 |
Why?
|
| Humans | 226 | 2024 | 261506 | 1.350 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 651 | 1.280 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 715 | 1.260 |
Why?
|
| Placenta | 6 | 2021 | 516 | 1.240 |
Why?
|
| Cell Differentiation | 23 | 2018 | 4078 | 1.220 |
Why?
|
| Mice, Transgenic | 32 | 2022 | 4143 | 1.220 |
Why?
|
| Mice, Inbred C57BL | 43 | 2021 | 6942 | 1.220 |
Why?
|
| CRISPR-Cas Systems | 2 | 2021 | 323 | 1.150 |
Why?
|
| Wound Healing | 6 | 2022 | 815 | 1.100 |
Why?
|
| Thrombospondin 1 | 6 | 2014 | 55 | 1.090 |
Why?
|
| Kidney Tubules | 10 | 2020 | 137 | 1.080 |
Why?
|
| Cell Transdifferentiation | 4 | 2015 | 112 | 1.070 |
Why?
|
| Epithelium | 9 | 2015 | 720 | 1.070 |
Why?
|
| Cell Movement | 16 | 2021 | 2466 | 1.070 |
Why?
|
| Integrin beta1 | 5 | 2022 | 126 | 1.060 |
Why?
|
| Transforming Growth Factor beta1 | 15 | 2021 | 292 | 1.030 |
Why?
|
| Betacoronavirus | 2 | 2020 | 527 | 1.020 |
Why?
|
| Integrin alpha1beta1 | 5 | 2013 | 9 | 1.020 |
Why?
|
| Snail Family Transcription Factors | 3 | 2021 | 120 | 1.010 |
Why?
|
| Disease Models, Animal | 31 | 2021 | 7222 | 1.000 |
Why?
|
| Extracellular Matrix Proteins | 8 | 2011 | 315 | 1.000 |
Why?
|
| Gene Expression Regulation | 11 | 2021 | 4053 | 0.960 |
Why?
|
| Models, Biological | 18 | 2018 | 3254 | 0.950 |
Why?
|
| Breast Neoplasms | 14 | 2020 | 15694 | 0.940 |
Why?
|
| MicroRNAs | 9 | 2017 | 2947 | 0.940 |
Why?
|
| DNA | 9 | 2018 | 2693 | 0.940 |
Why?
|
| Peptide Fragments | 15 | 2011 | 1271 | 0.930 |
Why?
|
| Disease Progression | 30 | 2021 | 6682 | 0.930 |
Why?
|
| Pericytes | 4 | 2015 | 96 | 0.930 |
Why?
|
| Kidney Failure, Chronic | 11 | 2018 | 960 | 0.920 |
Why?
|
| Renin-Angiotensin System | 3 | 2021 | 103 | 0.920 |
Why?
|
| Proteinuria | 12 | 2009 | 155 | 0.920 |
Why?
|
| S100 Proteins | 5 | 2011 | 181 | 0.920 |
Why?
|
| Pandemics | 4 | 2022 | 1559 | 0.900 |
Why?
|
| Acute Kidney Injury | 5 | 2021 | 739 | 0.900 |
Why?
|
| Cell Line, Tumor | 22 | 2023 | 14551 | 0.900 |
Why?
|
| Mice, Knockout | 27 | 2021 | 5710 | 0.900 |
Why?
|
| Recombinant Proteins | 25 | 2015 | 2927 | 0.890 |
Why?
|
| Cell-Derived Microparticles | 2 | 2020 | 41 | 0.880 |
Why?
|
| Twist-Related Protein 1 | 2 | 2021 | 127 | 0.880 |
Why?
|
| STAT3 Transcription Factor | 3 | 2021 | 1121 | 0.880 |
Why?
|
| Liver Cirrhosis | 5 | 2021 | 941 | 0.880 |
Why?
|
| Placenta Growth Factor | 2 | 2020 | 35 | 0.840 |
Why?
|
| Bone Marrow Cells | 7 | 2013 | 943 | 0.840 |
Why?
|
| Proteome | 3 | 2024 | 561 | 0.830 |
Why?
|
| Carrier Proteins | 5 | 2021 | 2022 | 0.820 |
Why?
|
| Syntenins | 1 | 2021 | 4 | 0.810 |
Why?
|
| Zebrafish | 3 | 2023 | 463 | 0.810 |
Why?
|
| Osteogenesis | 2 | 2021 | 271 | 0.800 |
Why?
|
| Nucleotides, Cyclic | 1 | 2021 | 10 | 0.800 |
Why?
|
| Colorectal Neoplasms | 5 | 2021 | 3578 | 0.780 |
Why?
|
| Embryonic Development | 2 | 2021 | 306 | 0.780 |
Why?
|
| Nucleocapsid | 1 | 2020 | 12 | 0.770 |
Why?
|
| Myocardium | 5 | 2013 | 1313 | 0.770 |
Why?
|
| Mass Vaccination | 1 | 2020 | 21 | 0.760 |
Why?
|
| Quarantine | 1 | 2020 | 20 | 0.750 |
Why?
|
| Collagen Type XVIII | 7 | 2013 | 17 | 0.750 |
Why?
|
| Diabetic Nephropathies | 10 | 2012 | 183 | 0.750 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2021 | 159 | 0.750 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2021 | 248 | 0.750 |
Why?
|
| Cell Lineage | 6 | 2021 | 668 | 0.740 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2021 | 88 | 0.730 |
Why?
|
| Fas Ligand Protein | 1 | 2020 | 150 | 0.730 |
Why?
|
| S100 Calcium-Binding Protein A4 | 9 | 2018 | 57 | 0.730 |
Why?
|
| Gene Targeting | 1 | 2021 | 292 | 0.730 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2021 | 140 | 0.720 |
Why?
|
| Melanoma, Experimental | 2 | 2021 | 368 | 0.720 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 284 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2021 | 72 | 0.710 |
Why?
|
| Drug Delivery Systems | 2 | 2021 | 669 | 0.710 |
Why?
|
| Kidney Transplantation | 8 | 2010 | 755 | 0.700 |
Why?
|
| Membrane Glycoproteins | 3 | 2018 | 1073 | 0.700 |
Why?
|
| Membrane Proteins | 14 | 2021 | 2819 | 0.700 |
Why?
|
| Antibodies | 12 | 2015 | 838 | 0.690 |
Why?
|
| Laminin | 10 | 2009 | 194 | 0.690 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 222 | 0.690 |
Why?
|
| Carcinogenesis | 6 | 2022 | 1026 | 0.690 |
Why?
|
| Body Fluids | 1 | 2020 | 125 | 0.680 |
Why?
|
| Blood Vessels | 3 | 2015 | 217 | 0.680 |
Why?
|
| Glomerular Basement Membrane | 4 | 2024 | 22 | 0.680 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2012 | 650 | 0.680 |
Why?
|
| Cells, Cultured | 31 | 2017 | 5637 | 0.670 |
Why?
|
| Gene Editing | 1 | 2021 | 216 | 0.670 |
Why?
|
| Biomarkers, Tumor | 10 | 2024 | 10331 | 0.670 |
Why?
|
| Vascular Endothelial Growth Factor A | 12 | 2012 | 1533 | 0.660 |
Why?
|
| Blood Pressure | 4 | 2021 | 1467 | 0.660 |
Why?
|
| Mice, Inbred BALB C | 11 | 2021 | 2314 | 0.650 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2021 | 2326 | 0.630 |
Why?
|
| Immunity, Innate | 2 | 2021 | 677 | 0.630 |
Why?
|
| Liver | 4 | 2013 | 2961 | 0.620 |
Why?
|
| Hepatocytes | 4 | 2018 | 351 | 0.620 |
Why?
|
| Proteoglycans | 8 | 2015 | 259 | 0.620 |
Why?
|
| Actins | 10 | 2021 | 608 | 0.620 |
Why?
|
| DNA Methylation | 8 | 2018 | 2669 | 0.620 |
Why?
|
| Urothelium | 3 | 2014 | 254 | 0.610 |
Why?
|
| BCG Vaccine | 1 | 2020 | 399 | 0.610 |
Why?
|
| Cell Proliferation | 17 | 2023 | 7226 | 0.610 |
Why?
|
| Gene Expression Regulation, Neoplastic | 15 | 2021 | 8873 | 0.610 |
Why?
|
| Estradiol | 3 | 2010 | 748 | 0.600 |
Why?
|
| Female | 73 | 2021 | 141928 | 0.600 |
Why?
|
| Catechol O-Methyltransferase | 4 | 2010 | 34 | 0.590 |
Why?
|
| Receptors, Transforming Growth Factor beta | 6 | 2013 | 229 | 0.590 |
Why?
|
| Biological Products | 1 | 2020 | 274 | 0.590 |
Why?
|
| Integrins | 7 | 2008 | 262 | 0.580 |
Why?
|
| Carcinoma, Lewis Lung | 4 | 2008 | 35 | 0.570 |
Why?
|
| Epitopes | 7 | 2005 | 685 | 0.560 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 541 | 0.560 |
Why?
|
| Integrin alphaVbeta3 | 4 | 2008 | 45 | 0.560 |
Why?
|
| Urinary Bladder, Overactive | 2 | 2013 | 37 | 0.550 |
Why?
|
| Models, Theoretical | 1 | 2020 | 785 | 0.550 |
Why?
|
| Lymphatic System | 2 | 2018 | 64 | 0.550 |
Why?
|
| Lymphangiogenesis | 2 | 2018 | 46 | 0.540 |
Why?
|
| Immunity | 1 | 2018 | 342 | 0.540 |
Why?
|
| Cattle | 20 | 2008 | 783 | 0.540 |
Why?
|
| ras Proteins | 5 | 2015 | 770 | 0.540 |
Why?
|
| Molecular Sequence Data | 28 | 2015 | 6089 | 0.540 |
Why?
|
| Smad4 Protein | 3 | 2018 | 196 | 0.540 |
Why?
|
| Cell Membrane | 2 | 2019 | 850 | 0.540 |
Why?
|
| GTPase-Activating Proteins | 4 | 2018 | 126 | 0.530 |
Why?
|
| Cell Line | 15 | 2018 | 5114 | 0.520 |
Why?
|
| Proteomics | 3 | 2021 | 1380 | 0.510 |
Why?
|
| Amino Acid Sequence | 25 | 2015 | 4233 | 0.510 |
Why?
|
| DNA, Neoplasm | 3 | 2017 | 1910 | 0.500 |
Why?
|
| Kidney Neoplasms | 4 | 2021 | 3022 | 0.500 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 68 | 0.500 |
Why?
|
| Promoter Regions, Genetic | 9 | 2018 | 3101 | 0.500 |
Why?
|
| Protein Structure, Tertiary | 12 | 2010 | 1487 | 0.500 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 17 | 2008 | 1489 | 0.500 |
Why?
|
| Nephritis | 7 | 2014 | 36 | 0.490 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2023 | 1215 | 0.490 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2015 | 1498 | 0.480 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2017 | 3552 | 0.480 |
Why?
|
| Tuberculosis | 1 | 2020 | 548 | 0.480 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2014 | 62 | 0.480 |
Why?
|
| Drug Therapy | 2 | 2018 | 205 | 0.470 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1320 | 0.470 |
Why?
|
| Erythropoietin | 1 | 2015 | 205 | 0.470 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 2013 | 15 | 0.460 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 4 | 2018 | 125 | 0.460 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 1022 | 0.460 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 1399 | 0.460 |
Why?
|
| Chromosomes, Human | 2 | 2014 | 295 | 0.460 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 253 | 0.450 |
Why?
|
| Receptors, Vitronectin | 3 | 2002 | 24 | 0.450 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2016 | 5178 | 0.450 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2016 | 2488 | 0.450 |
Why?
|
| Regeneration | 6 | 2013 | 279 | 0.440 |
Why?
|
| Male | 60 | 2021 | 123000 | 0.440 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2016 | 787 | 0.440 |
Why?
|
| Pregnancy | 14 | 2021 | 7573 | 0.440 |
Why?
|
| Glomerulonephritis | 10 | 2010 | 109 | 0.440 |
Why?
|
| Immunotherapy | 3 | 2020 | 3341 | 0.430 |
Why?
|
| Protein Binding | 12 | 2022 | 3438 | 0.430 |
Why?
|
| Stem Cells | 4 | 2024 | 1213 | 0.430 |
Why?
|
| Transforming Growth Factor beta2 | 2 | 2011 | 32 | 0.430 |
Why?
|
| Transcription Factors | 5 | 2015 | 5270 | 0.430 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 7 | 2009 | 157 | 0.420 |
Why?
|
| Calcium-Binding Proteins | 5 | 2008 | 545 | 0.420 |
Why?
|
| Coronary Vessels | 2 | 2014 | 665 | 0.420 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 146 | 0.420 |
Why?
|
| Smad Proteins | 2 | 2015 | 88 | 0.420 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 992 | 0.410 |
Why?
|
| Reperfusion Injury | 2 | 2016 | 145 | 0.410 |
Why?
|
| Matrix Metalloproteinase 9 | 4 | 2013 | 360 | 0.410 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 907 | 0.410 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2017 | 1016 | 0.410 |
Why?
|
| B-Lymphocytes | 4 | 2020 | 1294 | 0.410 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2011 | 104 | 0.400 |
Why?
|
| Tenascin | 1 | 2011 | 56 | 0.400 |
Why?
|
| Ureteral Obstruction | 2 | 2014 | 143 | 0.400 |
Why?
|
| Phenotype | 8 | 2021 | 6295 | 0.400 |
Why?
|
| Immunohistochemistry | 16 | 2017 | 7548 | 0.390 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 848 | 0.390 |
Why?
|
| Nuclear Proteins | 2 | 2021 | 3343 | 0.390 |
Why?
|
| Oncogenes | 3 | 2021 | 673 | 0.380 |
Why?
|
| Cicatrix | 1 | 2012 | 208 | 0.380 |
Why?
|
| Proto-Oncogene Proteins c-met | 3 | 2021 | 419 | 0.380 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2003 | 46 | 0.380 |
Why?
|
| Myocardial Ischemia | 1 | 2014 | 435 | 0.380 |
Why?
|
| Cell Hypoxia | 6 | 2015 | 328 | 0.380 |
Why?
|
| Chondrocytes | 1 | 2011 | 107 | 0.380 |
Why?
|
| Cartilage | 1 | 2011 | 128 | 0.370 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2017 | 5539 | 0.370 |
Why?
|
| MCF-7 Cells | 5 | 2021 | 550 | 0.370 |
Why?
|
| Liver Neoplasms | 3 | 2021 | 4557 | 0.360 |
Why?
|
| Liquid Biopsy | 2 | 2020 | 158 | 0.350 |
Why?
|
| Antineoplastic Agents | 12 | 2022 | 14289 | 0.350 |
Why?
|
| Population Groups | 1 | 2009 | 42 | 0.350 |
Why?
|
| Survival Analysis | 7 | 2022 | 9180 | 0.350 |
Why?
|
| T-Lymphocytes | 8 | 2020 | 3869 | 0.340 |
Why?
|
| Anemia | 1 | 2015 | 689 | 0.340 |
Why?
|
| Myocytes, Cardiac | 2 | 2015 | 764 | 0.340 |
Why?
|
| Liver Neoplasms, Experimental | 3 | 2021 | 196 | 0.340 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 170 | 0.340 |
Why?
|
| Trophoblasts | 1 | 2010 | 138 | 0.340 |
Why?
|
| Losartan | 2 | 2008 | 46 | 0.340 |
Why?
|
| Immunomodulation | 2 | 2020 | 242 | 0.330 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2008 | 1823 | 0.330 |
Why?
|
| Dinosaurs | 3 | 2015 | 5 | 0.330 |
Why?
|
| NIH 3T3 Cells | 5 | 2021 | 260 | 0.330 |
Why?
|
| Liver Regeneration | 2 | 2006 | 134 | 0.330 |
Why?
|
| Gene Deletion | 6 | 2011 | 1442 | 0.330 |
Why?
|
| Immunity, Cellular | 2 | 2003 | 419 | 0.330 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2005 | 106 | 0.330 |
Why?
|
| HEK293 Cells | 3 | 2022 | 1489 | 0.330 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2008 | 23 | 0.320 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 423 | 0.320 |
Why?
|
| Insulinoma | 1 | 2008 | 55 | 0.320 |
Why?
|
| Bone Marrow | 2 | 2021 | 2358 | 0.320 |
Why?
|
| Growth Substances | 3 | 2003 | 300 | 0.320 |
Why?
|
| Mitochondria | 2 | 2014 | 1282 | 0.320 |
Why?
|
| Carbon Tetrachloride | 2 | 2021 | 24 | 0.320 |
Why?
|
| Blotting, Western | 9 | 2017 | 3536 | 0.310 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2007 | 9 | 0.310 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 307 | 0.310 |
Why?
|
| Liver Diseases | 1 | 2013 | 574 | 0.310 |
Why?
|
| Antigens, CD | 3 | 2015 | 1385 | 0.310 |
Why?
|
| Pyridoxamine | 1 | 2007 | 1 | 0.310 |
Why?
|
| Renal Agents | 1 | 2007 | 6 | 0.310 |
Why?
|
| Neoplastic Stem Cells | 5 | 2021 | 1443 | 0.300 |
Why?
|
| Gene Silencing | 3 | 2017 | 837 | 0.300 |
Why?
|
| Guanidines | 1 | 2007 | 60 | 0.300 |
Why?
|
| Inflammation | 3 | 2021 | 2522 | 0.300 |
Why?
|
| Genes, Reporter | 4 | 2021 | 798 | 0.300 |
Why?
|
| Proteins | 9 | 2013 | 1963 | 0.300 |
Why?
|
| Apoptosis | 11 | 2023 | 7591 | 0.300 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 494 | 0.290 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 4 | 2010 | 43 | 0.290 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2006 | 34 | 0.290 |
Why?
|
| Biomarkers | 9 | 2024 | 5047 | 0.290 |
Why?
|
| Marfan Syndrome | 1 | 2008 | 142 | 0.290 |
Why?
|
| Protein Isoforms | 5 | 2012 | 842 | 0.290 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 533 | 0.280 |
Why?
|
| Mice, Inbred Strains | 7 | 2010 | 521 | 0.280 |
Why?
|
| Heart Valves | 1 | 2006 | 66 | 0.280 |
Why?
|
| Mutation | 14 | 2017 | 15179 | 0.280 |
Why?
|
| Antibody Specificity | 9 | 2005 | 334 | 0.280 |
Why?
|
| Neoplasm Invasiveness | 7 | 2021 | 3981 | 0.280 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 5 | 2020 | 376 | 0.280 |
Why?
|
| Matrix Metalloproteinase 2 | 3 | 2006 | 256 | 0.280 |
Why?
|
| Femur | 2 | 2021 | 158 | 0.280 |
Why?
|
| Gene Expression | 13 | 2020 | 3570 | 0.280 |
Why?
|
| Peptides | 4 | 2013 | 1479 | 0.270 |
Why?
|
| Cell Division | 8 | 2005 | 2489 | 0.270 |
Why?
|
| Bone Marrow Transplantation | 2 | 2008 | 1581 | 0.270 |
Why?
|
| Drug Combinations | 6 | 2008 | 621 | 0.270 |
Why?
|
| Glomerulonephritis, Membranous | 3 | 2010 | 17 | 0.270 |
Why?
|
| Protein Subunits | 2 | 2023 | 274 | 0.270 |
Why?
|
| Stomach Neoplasms | 1 | 2018 | 2278 | 0.270 |
Why?
|
| Endothelial Growth Factors | 2 | 2003 | 197 | 0.260 |
Why?
|
| Oxygen | 1 | 2010 | 754 | 0.260 |
Why?
|
| Intestines | 1 | 2010 | 686 | 0.260 |
Why?
|
| Cytokines | 5 | 2016 | 2809 | 0.260 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2021 | 142 | 0.260 |
Why?
|
| Cochlea | 3 | 2005 | 102 | 0.260 |
Why?
|
| Lymphokines | 2 | 2003 | 272 | 0.260 |
Why?
|
| Smad3 Protein | 3 | 2013 | 129 | 0.260 |
Why?
|
| Rats | 23 | 2022 | 6086 | 0.260 |
Why?
|
| Thymidine Kinase | 2 | 2018 | 193 | 0.260 |
Why?
|
| Fluorescent Antibody Technique | 8 | 2015 | 1062 | 0.260 |
Why?
|
| RNA Interference | 6 | 2020 | 1408 | 0.260 |
Why?
|
| Neoplasms, Experimental | 3 | 2011 | 750 | 0.250 |
Why?
|
| Cadherins | 6 | 2015 | 660 | 0.250 |
Why?
|
| Fossils | 3 | 2015 | 14 | 0.250 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2006 | 221 | 0.250 |
Why?
|
| Gene Expression Profiling | 6 | 2021 | 5159 | 0.250 |
Why?
|
| Hepatic Stellate Cells | 2 | 2021 | 30 | 0.250 |
Why?
|
| Isoantibodies | 3 | 1995 | 115 | 0.250 |
Why?
|
| Killer Cells, Natural | 3 | 2020 | 904 | 0.240 |
Why?
|
| Heart Diseases | 1 | 2010 | 732 | 0.240 |
Why?
|
| Integrin alpha2beta1 | 1 | 2003 | 8 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2017 | 2359 | 0.240 |
Why?
|
| Stem Cell Transplantation | 2 | 2017 | 1360 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 9 | 2012 | 5395 | 0.240 |
Why?
|
| Case-Control Studies | 8 | 2021 | 6100 | 0.230 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2019 | 1265 | 0.230 |
Why?
|
| Integrin alpha5beta1 | 1 | 2003 | 12 | 0.230 |
Why?
|
| Breast | 1 | 2010 | 1344 | 0.230 |
Why?
|
| Lymphocytes | 2 | 2008 | 1234 | 0.230 |
Why?
|
| Microfilament Proteins | 4 | 2008 | 487 | 0.230 |
Why?
|
| Macrophages | 2 | 2020 | 1304 | 0.230 |
Why?
|
| Glomerular Mesangium | 2 | 2002 | 40 | 0.230 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2013 | 32 | 0.220 |
Why?
|
| RNA-Binding Proteins | 3 | 2014 | 984 | 0.220 |
Why?
|
| RNA, Messenger | 17 | 2021 | 6150 | 0.220 |
Why?
|
| Immunoglobulin G | 7 | 2010 | 1021 | 0.220 |
Why?
|
| Fetal Blood | 1 | 2005 | 482 | 0.210 |
Why?
|
| Chronic Disease | 6 | 2008 | 1819 | 0.210 |
Why?
|
| Plasmids | 2 | 2021 | 837 | 0.210 |
Why?
|
| X Chromosome | 4 | 1997 | 339 | 0.210 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2014 | 154 | 0.210 |
Why?
|
| Diagnostic Errors | 2 | 2005 | 509 | 0.210 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.210 |
Why?
|
| Organophosphonates | 1 | 2022 | 64 | 0.210 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 71 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 2330 | 0.210 |
Why?
|
| Time Factors | 13 | 2015 | 12926 | 0.210 |
Why?
|
| Capillary Permeability | 1 | 2002 | 114 | 0.210 |
Why?
|
| Thionucleosides | 1 | 2021 | 12 | 0.200 |
Why?
|
| RNA | 4 | 2018 | 1013 | 0.200 |
Why?
|
| THP-1 Cells | 1 | 2021 | 55 | 0.200 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 57 | 0.200 |
Why?
|
| DNA-Binding Proteins | 6 | 2016 | 4821 | 0.200 |
Why?
|
| Machine Learning | 1 | 2024 | 319 | 0.200 |
Why?
|
| Deoxyadenosines | 1 | 2021 | 42 | 0.200 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2021 | 46 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2010 | 997 | 0.200 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 834 | 0.200 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2021 | 81 | 0.200 |
Why?
|
| Immunoblotting | 8 | 2010 | 886 | 0.200 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 368 | 0.190 |
Why?
|
| Isotope Labeling | 1 | 2021 | 142 | 0.190 |
Why?
|
| Lung Diseases | 2 | 2005 | 717 | 0.190 |
Why?
|
| RNA, Neoplasm | 2 | 2016 | 771 | 0.190 |
Why?
|
| Bioengineering | 1 | 2021 | 27 | 0.190 |
Why?
|
| Mice, Mutant Strains | 4 | 2011 | 634 | 0.190 |
Why?
|
| Seroconversion | 1 | 2020 | 19 | 0.190 |
Why?
|
| Cathepsins | 3 | 2009 | 46 | 0.190 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2021 | 76 | 0.190 |
Why?
|
| Isoantigens | 2 | 2000 | 62 | 0.190 |
Why?
|
| Mice, Nude | 8 | 2017 | 4307 | 0.190 |
Why?
|
| Jurkat Cells | 1 | 2021 | 311 | 0.190 |
Why?
|
| Leukemia | 1 | 2009 | 1635 | 0.190 |
Why?
|
| Cell Engineering | 1 | 2020 | 37 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 2291 | 0.190 |
Why?
|
| Glucose | 3 | 2020 | 1248 | 0.190 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 41 | 0.190 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2014 | 252 | 0.190 |
Why?
|
| Bile Duct Neoplasms | 2 | 2021 | 493 | 0.190 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 470 | 0.190 |
Why?
|
| Indoles | 3 | 2012 | 1009 | 0.190 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 43 | 0.190 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2005 | 600 | 0.190 |
Why?
|
| Cholangiocarcinoma | 2 | 2021 | 493 | 0.180 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 8 | 2008 | 568 | 0.180 |
Why?
|
| Serologic Tests | 1 | 2020 | 137 | 0.180 |
Why?
|
| Protein Conformation | 8 | 2008 | 1258 | 0.180 |
Why?
|
| Cell Cycle Checkpoints | 3 | 2020 | 278 | 0.180 |
Why?
|
| Immune Evasion | 1 | 2020 | 73 | 0.180 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 717 | 0.180 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2021 | 83 | 0.180 |
Why?
|
| Biological Transport | 1 | 2021 | 597 | 0.180 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2020 | 33 | 0.180 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 223 | 0.180 |
Why?
|
| Monocytes | 3 | 2020 | 788 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2018 | 518 | 0.180 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2020 | 100 | 0.180 |
Why?
|
| Imidazoline Receptors | 1 | 2019 | 3 | 0.180 |
Why?
|
| Gene Transfer Techniques | 2 | 2021 | 716 | 0.180 |
Why?
|
| Graft Rejection | 1 | 2004 | 834 | 0.180 |
Why?
|
| Adaptive Immunity | 1 | 2020 | 149 | 0.170 |
Why?
|
| Bayes Theorem | 1 | 2024 | 1021 | 0.170 |
Why?
|
| Allografts | 1 | 2021 | 650 | 0.170 |
Why?
|
| Creatine | 2 | 2010 | 61 | 0.170 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 651 | 0.170 |
Why?
|
| Lupus Nephritis | 5 | 2004 | 48 | 0.170 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 203 | 0.170 |
Why?
|
| Epitope Mapping | 4 | 2005 | 108 | 0.170 |
Why?
|
| Activin Receptors, Type I | 3 | 2010 | 50 | 0.170 |
Why?
|
| beta-Galactosidase | 2 | 2010 | 211 | 0.170 |
Why?
|
| Lung | 8 | 2014 | 3151 | 0.170 |
Why?
|
| Glycogen | 1 | 2018 | 80 | 0.170 |
Why?
|
| Alleles | 4 | 2021 | 2437 | 0.170 |
Why?
|
| Epigenomics | 1 | 2020 | 266 | 0.170 |
Why?
|
| Glucuronidase | 1 | 2018 | 48 | 0.160 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 89 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 1081 | 0.160 |
Why?
|
| Prognosis | 6 | 2020 | 21713 | 0.160 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2018 | 15 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 2027 | 0.160 |
Why?
|
| Microscopy, Electron | 6 | 2017 | 600 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 216 | 0.160 |
Why?
|
| Protein Biosynthesis | 2 | 2002 | 889 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2020 | 130 | 0.160 |
Why?
|
| Immune Tolerance | 4 | 2014 | 403 | 0.160 |
Why?
|
| Forecasting | 2 | 2016 | 694 | 0.160 |
Why?
|
| Renal Insufficiency | 2 | 2014 | 321 | 0.160 |
Why?
|
| Genotype | 5 | 2016 | 4109 | 0.160 |
Why?
|
| Models, Molecular | 5 | 2011 | 1732 | 0.160 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 189 | 0.160 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2010 | 224 | 0.160 |
Why?
|
| Drug Monitoring | 1 | 2020 | 333 | 0.160 |
Why?
|
| Lentivirus | 1 | 2018 | 169 | 0.160 |
Why?
|
| Genes, MHC Class II | 1 | 1997 | 67 | 0.160 |
Why?
|
| Albumins | 2 | 2010 | 258 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 7 | 2017 | 3203 | 0.150 |
Why?
|
| Reproduction | 1 | 2020 | 253 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 488 | 0.150 |
Why?
|
| Crosses, Genetic | 2 | 2008 | 241 | 0.150 |
Why?
|
| Health Policy | 1 | 2020 | 291 | 0.150 |
Why?
|
| Adenocarcinoma | 5 | 2017 | 7789 | 0.150 |
Why?
|
| Lymphatic Vessels | 1 | 2018 | 143 | 0.150 |
Why?
|
| Interleukin-6 | 1 | 2022 | 1038 | 0.150 |
Why?
|
| Cyclophosphamide | 2 | 2004 | 3001 | 0.150 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 406 | 0.150 |
Why?
|
| Atrophy | 2 | 2010 | 261 | 0.150 |
Why?
|
| Spatial Analysis | 1 | 2017 | 35 | 0.150 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2008 | 611 | 0.150 |
Why?
|
| Biological Assay | 1 | 2018 | 177 | 0.150 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 987 | 0.150 |
Why?
|
| Phosphoproteins | 3 | 2013 | 1152 | 0.150 |
Why?
|
| Hydralazine | 1 | 2016 | 9 | 0.150 |
Why?
|
| Receptors, Cell Surface | 3 | 2011 | 862 | 0.150 |
Why?
|
| Neurodegenerative Diseases | 1 | 2020 | 264 | 0.150 |
Why?
|
| Skin | 2 | 2022 | 1259 | 0.140 |
Why?
|
| Lysosomes | 1 | 2019 | 347 | 0.140 |
Why?
|
| Species Specificity | 3 | 2015 | 777 | 0.140 |
Why?
|
| Spectrum Analysis | 1 | 2017 | 139 | 0.140 |
Why?
|
| Integrin beta3 | 2 | 2007 | 44 | 0.140 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2015 | 153 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 3 | 2013 | 143 | 0.140 |
Why?
|
| Integrin beta Chains | 1 | 2016 | 34 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 643 | 0.140 |
Why?
|
| Kidney Tubules, Proximal | 4 | 2001 | 142 | 0.140 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2015 | 12 | 0.140 |
Why?
|
| Antigens | 2 | 2015 | 292 | 0.140 |
Why?
|
| Neutrophils | 1 | 2020 | 835 | 0.140 |
Why?
|
| Osteopontin | 3 | 2015 | 148 | 0.140 |
Why?
|
| Microbiota | 1 | 2022 | 547 | 0.140 |
Why?
|
| Clinical Trials as Topic | 3 | 2020 | 3719 | 0.140 |
Why?
|
| Endopeptidases | 1 | 1997 | 220 | 0.140 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 309 | 0.130 |
Why?
|
| Integrases | 3 | 2018 | 262 | 0.130 |
Why?
|
| Cloning, Molecular | 5 | 2008 | 1213 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2020 | 810 | 0.130 |
Why?
|
| Actinin | 2 | 2006 | 21 | 0.130 |
Why?
|
| Transfection | 5 | 2015 | 2944 | 0.130 |
Why?
|
| Glypicans | 1 | 2015 | 51 | 0.130 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2015 | 12 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 760 | 0.130 |
Why?
|
| Base Sequence | 10 | 2005 | 4917 | 0.130 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 219 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2005 | 1764 | 0.130 |
Why?
|
| Renin | 1 | 2015 | 92 | 0.130 |
Why?
|
| CD24 Antigen | 1 | 2015 | 85 | 0.130 |
Why?
|
| Endocardium | 1 | 2015 | 50 | 0.130 |
Why?
|
| Angiopoietin-2 | 1 | 2015 | 38 | 0.130 |
Why?
|
| Carboxypeptidases | 1 | 2014 | 27 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2018 | 448 | 0.130 |
Why?
|
| Neoplasm Transplantation | 5 | 2008 | 1519 | 0.130 |
Why?
|
| Cell Adhesion | 3 | 2010 | 1008 | 0.130 |
Why?
|
| Argonaute Proteins | 1 | 2014 | 40 | 0.130 |
Why?
|
| Neural Crest | 1 | 2015 | 85 | 0.120 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 73 | 0.120 |
Why?
|
| Camptothecin | 1 | 2017 | 517 | 0.120 |
Why?
|
| Nephrosclerosis | 1 | 2014 | 13 | 0.120 |
Why?
|
| Carcinoma in Situ | 2 | 2011 | 487 | 0.120 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 749 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2020 | 1085 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 3154 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2015 | 467 | 0.120 |
Why?
|
| Urinary Bladder | 2 | 2014 | 575 | 0.120 |
Why?
|
| Amino Acid Substitution | 2 | 2008 | 644 | 0.120 |
Why?
|
| Middle Aged | 14 | 2021 | 86204 | 0.120 |
Why?
|
| Ribonuclease III | 1 | 2014 | 182 | 0.120 |
Why?
|
| Sequence Alignment | 3 | 2015 | 844 | 0.120 |
Why?
|
| Survival Rate | 5 | 2017 | 12221 | 0.110 |
Why?
|
| Bevacizumab | 2 | 2008 | 938 | 0.110 |
Why?
|
| Diarrhea | 1 | 2017 | 686 | 0.110 |
Why?
|
| Genetic Therapy | 2 | 2018 | 1616 | 0.110 |
Why?
|
| Th1 Cells | 2 | 2009 | 250 | 0.110 |
Why?
|
| Glycation End Products, Advanced | 2 | 2007 | 31 | 0.110 |
Why?
|
| Rabbits | 5 | 2010 | 957 | 0.110 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 401 | 0.110 |
Why?
|
| Arrestin | 2 | 2004 | 4 | 0.110 |
Why?
|
| Adenosine | 1 | 2015 | 289 | 0.110 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 255 | 0.110 |
Why?
|
| Fibronectins | 2 | 2003 | 197 | 0.110 |
Why?
|
| Vitronectin | 2 | 2003 | 22 | 0.110 |
Why?
|
| Creatinine | 3 | 2014 | 531 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 806 | 0.110 |
Why?
|
| Algorithms | 1 | 2024 | 3890 | 0.110 |
Why?
|
| Microcirculation | 3 | 2009 | 200 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.110 |
Why?
|
| Interleukin-12 | 2 | 2008 | 253 | 0.110 |
Why?
|
| Sequence Deletion | 3 | 2021 | 875 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 1995 | 402 | 0.100 |
Why?
|
| Focal Adhesion Kinase 1 | 2 | 2003 | 111 | 0.100 |
Why?
|
| Homozygote | 3 | 2021 | 717 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 4971 | 0.100 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2021 | 334 | 0.100 |
Why?
|
| Reptilian Proteins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2013 | 194 | 0.100 |
Why?
|
| Pericardium | 1 | 2013 | 157 | 0.100 |
Why?
|
| Coumarins | 2 | 2002 | 33 | 0.100 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2003 | 161 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2012 | 1439 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 5 | 1 | 2011 | 9 | 0.100 |
Why?
|
| Enoxacin | 1 | 2011 | 8 | 0.100 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 90 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2011 | 114 | 0.100 |
Why?
|
| Propionates | 1 | 2011 | 71 | 0.100 |
Why?
|
| Imatinib Mesylate | 2 | 2015 | 1665 | 0.100 |
Why?
|
| Drug Synergism | 4 | 2010 | 1313 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 272 | 0.100 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2010 | 7 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2011 | 108 | 0.100 |
Why?
|
| Ganciclovir | 1 | 2011 | 174 | 0.100 |
Why?
|
| Ear | 1 | 2011 | 38 | 0.100 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 79 | 0.100 |
Why?
|
| Aorta | 4 | 2008 | 692 | 0.100 |
Why?
|
| Excitation Contraction Coupling | 1 | 2010 | 12 | 0.100 |
Why?
|
| Genes, ras | 1 | 2014 | 667 | 0.100 |
Why?
|
| Myositis Ossificans | 1 | 2010 | 30 | 0.100 |
Why?
|
| Benzenesulfonates | 1 | 2012 | 195 | 0.100 |
Why?
|
| Multipotent Stem Cells | 1 | 2010 | 52 | 0.100 |
Why?
|
| Pulmonary Artery | 2 | 2008 | 499 | 0.100 |
Why?
|
| Cell Death | 1 | 2013 | 671 | 0.090 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2001 | 54 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2011 | 469 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2021 | 1797 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2014 | 644 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2010 | 29 | 0.090 |
Why?
|
| Transcriptome | 2 | 2020 | 1859 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3821 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 3639 | 0.090 |
Why?
|
| Dioxygenases | 3 | 2016 | 159 | 0.090 |
Why?
|
| Albuminuria | 2 | 2008 | 113 | 0.090 |
Why?
|
| Niacinamide | 1 | 2012 | 421 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 122 | 0.090 |
Why?
|
| Binding, Competitive | 3 | 2003 | 300 | 0.090 |
Why?
|
| Animals, Newborn | 3 | 2015 | 1338 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 621 | 0.090 |
Why?
|
| Deoxycytidine | 1 | 2015 | 1353 | 0.090 |
Why?
|
| Aged | 11 | 2021 | 70117 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2001 | 471 | 0.090 |
Why?
|
| Placental Circulation | 1 | 2009 | 17 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2008 | 1143 | 0.090 |
Why?
|
| Structure-Activity Relationship | 2 | 2012 | 931 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2012 | 1113 | 0.090 |
Why?
|
| Receptor, PAR-1 | 1 | 2009 | 33 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2005 | 1555 | 0.090 |
Why?
|
| Adult | 18 | 2017 | 77950 | 0.090 |
Why?
|
| Venules | 1 | 2009 | 27 | 0.090 |
Why?
|
| Oligopeptides | 2 | 2003 | 429 | 0.090 |
Why?
|
| RNA, Long Noncoding | 1 | 2015 | 598 | 0.090 |
Why?
|
| Protein Kinases | 2 | 2005 | 874 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 154 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 694 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2011 | 169 | 0.090 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 94 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2010 | 337 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 6 | 2008 | 4367 | 0.090 |
Why?
|
| Myocardial Contraction | 1 | 2010 | 291 | 0.090 |
Why?
|
| Myoblasts | 1 | 2009 | 72 | 0.090 |
Why?
|
| Health | 1 | 2009 | 54 | 0.090 |
Why?
|
| Angiotensin II | 2 | 2001 | 198 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 267 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 610 | 0.080 |
Why?
|
| Ventricular Remodeling | 1 | 2010 | 248 | 0.080 |
Why?
|
| Mass Spectrometry | 3 | 2020 | 702 | 0.080 |
Why?
|
| Fibrillins | 1 | 2008 | 35 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 116 | 0.080 |
Why?
|
| Litter Size | 1 | 2008 | 26 | 0.080 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2010 | 192 | 0.080 |
Why?
|
| Transplantation, Homologous | 2 | 2010 | 2843 | 0.080 |
Why?
|
| United States | 2 | 2020 | 15433 | 0.080 |
Why?
|
| Caspases | 2 | 2001 | 661 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 2195 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 4 | 2004 | 492 | 0.080 |
Why?
|
| Aspartic Acid | 1 | 2008 | 126 | 0.080 |
Why?
|
| Phenylurea Compounds | 1 | 2012 | 580 | 0.080 |
Why?
|
| Cathepsin D | 1 | 2008 | 32 | 0.080 |
Why?
|
| bcl-X Protein | 1 | 2008 | 196 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2012 | 1064 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2008 | 769 | 0.080 |
Why?
|
| Renal Dialysis | 2 | 2010 | 945 | 0.080 |
Why?
|
| Transplantation, Heterologous | 3 | 2017 | 1082 | 0.080 |
Why?
|
| Tissue Engineering | 1 | 2010 | 269 | 0.080 |
Why?
|
| Benzamides | 2 | 2012 | 1832 | 0.080 |
Why?
|
| Fluorescent Dyes | 2 | 2007 | 459 | 0.080 |
Why?
|
| Valine | 1 | 2008 | 176 | 0.080 |
Why?
|
| Rhodamines | 1 | 2007 | 49 | 0.080 |
Why?
|
| Transgenes | 2 | 2007 | 557 | 0.080 |
Why?
|
| Amnion | 2 | 1999 | 33 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2018 | 2967 | 0.080 |
Why?
|
| Research | 1 | 2010 | 415 | 0.080 |
Why?
|
| Pyrroles | 1 | 2012 | 576 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 4113 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 2283 | 0.080 |
Why?
|
| Receptor, TIE-2 | 1 | 2008 | 82 | 0.080 |
Why?
|
| Disease | 1 | 2009 | 165 | 0.080 |
Why?
|
| Genes, Dominant | 1 | 2008 | 331 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2008 | 629 | 0.080 |
Why?
|
| Tissue Distribution | 4 | 2003 | 875 | 0.070 |
Why?
|
| Embryonic and Fetal Development | 2 | 1997 | 205 | 0.070 |
Why?
|
| Sirolimus | 1 | 2011 | 814 | 0.070 |
Why?
|
| Aging | 2 | 2006 | 1582 | 0.070 |
Why?
|
| CCAAT-Binding Factor | 1 | 2007 | 34 | 0.070 |
Why?
|
| RNA Splicing Factors | 1 | 2007 | 153 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 202 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2012 | 2450 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 289 | 0.070 |
Why?
|
| Leucine | 1 | 2008 | 352 | 0.070 |
Why?
|
| Models, Structural | 3 | 2004 | 103 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 340 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 4 | 2 | 2021 | 101 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 741 | 0.070 |
Why?
|
| Clone Cells | 2 | 2020 | 555 | 0.070 |
Why?
|
| Models, Animal | 1 | 2009 | 664 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2006 | 173 | 0.070 |
Why?
|
| Macular Degeneration | 1 | 2008 | 114 | 0.070 |
Why?
|
| Exons | 3 | 2005 | 1328 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2008 | 445 | 0.070 |
Why?
|
| Piperidines | 1 | 2012 | 1035 | 0.070 |
Why?
|
| Capillaries | 2 | 2003 | 99 | 0.070 |
Why?
|
| Substrate Specificity | 2 | 2006 | 549 | 0.070 |
Why?
|
| Colon | 1 | 2010 | 670 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2006 | 577 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 2045 | 0.070 |
Why?
|
| Glioma | 1 | 2017 | 1963 | 0.070 |
Why?
|
| Genomics | 1 | 2017 | 2738 | 0.070 |
Why?
|
| Structural Homology, Protein | 1 | 2005 | 42 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2008 | 3251 | 0.070 |
Why?
|
| Melanoma | 2 | 2020 | 5317 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2009 | 220 | 0.070 |
Why?
|
| Collagenases | 4 | 1999 | 74 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2003 | 80 | 0.070 |
Why?
|
| Mice, Inbred DBA | 2 | 2003 | 110 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2003 | 212 | 0.070 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 2005 | 2 | 0.070 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2018 | 74 | 0.070 |
Why?
|
| Escherichia coli | 3 | 2000 | 1203 | 0.070 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2010 | 363 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2000 | 189 | 0.070 |
Why?
|
| Hypoxia | 1 | 2008 | 443 | 0.070 |
Why?
|
| Rats, Wistar | 6 | 2005 | 562 | 0.070 |
Why?
|
| DNA Polymerase beta | 1 | 2005 | 19 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2000 | 4938 | 0.070 |
Why?
|
| Binding Sites | 3 | 2000 | 2171 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2016 | 257 | 0.060 |
Why?
|
| Sepharose | 1 | 2004 | 32 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 2508 | 0.060 |
Why?
|
| Tumor Burden | 1 | 2011 | 1987 | 0.060 |
Why?
|
| Organ Size | 1 | 2006 | 690 | 0.060 |
Why?
|
| DNA Ligases | 1 | 2005 | 63 | 0.060 |
Why?
|
| In Situ Hybridization | 6 | 2004 | 1037 | 0.060 |
Why?
|
| Prevalence | 2 | 2010 | 3260 | 0.060 |
Why?
|
| Pyridines | 1 | 2012 | 1244 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2015 | 4757 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2001 | 2084 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 1756 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3230 | 0.060 |
Why?
|
| Urethral Obstruction | 1 | 2005 | 56 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1538 | 0.060 |
Why?
|
| Macromolecular Substances | 3 | 1994 | 293 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2016 | 208 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 4849 | 0.060 |
Why?
|
| Prostatic Neoplasms | 2 | 2002 | 5767 | 0.060 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 88 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2005 | 197 | 0.060 |
Why?
|
| Nephrotic Syndrome | 1 | 2004 | 57 | 0.060 |
Why?
|
| Metalloendopeptidases | 3 | 1999 | 170 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2012 | 2063 | 0.060 |
Why?
|
| Introns | 1 | 2005 | 432 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2008 | 1144 | 0.060 |
Why?
|
| Nephritis, Interstitial | 1 | 2005 | 76 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2006 | 974 | 0.060 |
Why?
|
| Relaxin | 1 | 2003 | 21 | 0.060 |
Why?
|
| Radiography | 1 | 2008 | 1904 | 0.060 |
Why?
|
| Cell Survival | 2 | 2015 | 3045 | 0.060 |
Why?
|
| Smad5 Protein | 1 | 2003 | 27 | 0.060 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2003 | 16 | 0.060 |
Why?
|
| Mice, Inbred AKR | 1 | 2003 | 51 | 0.060 |
Why?
|
| Epidermal Growth Factor | 2 | 2003 | 423 | 0.060 |
Why?
|
| CpG Islands | 2 | 2016 | 633 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 42 | 0.060 |
Why?
|
| Sclerosis | 1 | 2003 | 84 | 0.060 |
Why?
|
| Heterozygote | 2 | 2003 | 1020 | 0.060 |
Why?
|
| Integrin alpha Chains | 1 | 2003 | 28 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2012 | 1471 | 0.060 |
Why?
|
| Radiation, Ionizing | 2 | 2000 | 187 | 0.060 |
Why?
|
| Serum Sickness | 2 | 1999 | 5 | 0.060 |
Why?
|
| Pregnancy, Animal | 1 | 2003 | 92 | 0.060 |
Why?
|
| Integrin alpha3beta1 | 1 | 2022 | 5 | 0.060 |
Why?
|
| Pancreatic Elastase | 3 | 1997 | 34 | 0.060 |
Why?
|
| Denys-Drash Syndrome | 1 | 2002 | 7 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 830 | 0.060 |
Why?
|
| Piperazines | 1 | 2012 | 2101 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 11538 | 0.050 |
Why?
|
| Plasma Exchange | 1 | 2003 | 117 | 0.050 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2002 | 95 | 0.050 |
Why?
|
| Genes, Wilms Tumor | 1 | 2002 | 64 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2003 | 157 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 4 | 1997 | 212 | 0.050 |
Why?
|
| RNA Caps | 1 | 2002 | 34 | 0.050 |
Why?
|
| Risk Factors | 2 | 2009 | 17523 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 45 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 1493 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 94 | 0.050 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2002 | 65 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 29902 | 0.050 |
Why?
|
| WT1 Proteins | 1 | 2002 | 106 | 0.050 |
Why?
|
| Primates | 1 | 2022 | 128 | 0.050 |
Why?
|
| Heart | 1 | 2008 | 1223 | 0.050 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2021 | 9 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 124 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 143 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 1217 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1270 | 0.050 |
Why?
|
| Alkylation | 1 | 2001 | 29 | 0.050 |
Why?
|
| Syndrome | 1 | 2005 | 1351 | 0.050 |
Why?
|
| Hyaluronan Synthases | 1 | 2021 | 20 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 2 | 2002 | 46 | 0.050 |
Why?
|
| Neutralization Tests | 1 | 2022 | 299 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2003 | 215 | 0.050 |
Why?
|
| Aminopeptidases | 1 | 2001 | 34 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2003 | 344 | 0.050 |
Why?
|
| Immune Sera | 1 | 2001 | 146 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2018 | 986 | 0.050 |
Why?
|
| Disulfides | 1 | 2001 | 116 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2021 | 105 | 0.050 |
Why?
|
| Thymus Gland | 1 | 2002 | 294 | 0.050 |
Why?
|
| Integrin alpha6beta1 | 1 | 2000 | 2 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 260 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2002 | 294 | 0.050 |
Why?
|
| Heart Failure | 1 | 2015 | 2516 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2020 | 32848 | 0.050 |
Why?
|
| Fetus | 2 | 2013 | 601 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2000 | 47 | 0.050 |
Why?
|
| Remission Induction | 1 | 2007 | 3569 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2003 | 905 | 0.050 |
Why?
|
| DNA Primers | 3 | 2001 | 1399 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2009 | 1423 | 0.050 |
Why?
|
| Developmental Biology | 1 | 2020 | 21 | 0.050 |
Why?
|
| Phylogeny | 2 | 2015 | 826 | 0.050 |
Why?
|
| Fibrinolysis | 1 | 2000 | 63 | 0.050 |
Why?
|
| Kinetics | 2 | 2000 | 2049 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 44 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2000 | 43 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 329 | 0.050 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2020 | 38 | 0.050 |
Why?
|
| Hepatectomy | 1 | 2006 | 1011 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 1506 | 0.050 |
Why?
|
| Labor, Obstetric | 2 | 1999 | 86 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 3 | 2005 | 40 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2000 | 151 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 168 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 217 | 0.040 |
Why?
|
| Cell Plasticity | 1 | 2020 | 66 | 0.040 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2021 | 209 | 0.040 |
Why?
|
| Symporters | 1 | 2020 | 98 | 0.040 |
Why?
|
| Allantois | 1 | 1999 | 6 | 0.040 |
Why?
|
| Protons | 1 | 2022 | 473 | 0.040 |
Why?
|
| North America | 1 | 2020 | 314 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2000 | 266 | 0.040 |
Why?
|
| Extraembryonic Membranes | 1 | 1999 | 13 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2012 | 3518 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2000 | 203 | 0.040 |
Why?
|
| Ligands | 1 | 2002 | 995 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 2000 | 155 | 0.040 |
Why?
|
| Systems Biology | 1 | 2019 | 112 | 0.040 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 133 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2002 | 602 | 0.040 |
Why?
|
| Chick Embryo | 1 | 1999 | 242 | 0.040 |
Why?
|
| YY1 Transcription Factor | 1 | 2018 | 18 | 0.040 |
Why?
|
| Homeostasis | 1 | 2004 | 950 | 0.040 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2018 | 22 | 0.040 |
Why?
|
| Hypertension | 1 | 2008 | 1503 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 305 | 0.040 |
Why?
|
| Rats, Inbred WKY | 3 | 2005 | 110 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 1643 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2011 | 2341 | 0.040 |
Why?
|
| Blotting, Northern | 4 | 2003 | 682 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2018 | 113 | 0.040 |
Why?
|
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2017 | 5 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2006 | 4804 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1998 | 241 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 15862 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2020 | 374 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 478 | 0.040 |
Why?
|
| Cathepsin B | 1 | 1997 | 32 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 1997 | 35 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 414 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1997 | 82 | 0.040 |
Why?
|
| Cathepsin G | 1 | 1997 | 23 | 0.040 |
Why?
|
| Seminiferous Tubules | 1 | 1997 | 52 | 0.040 |
Why?
|
| Pinocytosis | 1 | 2017 | 28 | 0.040 |
Why?
|
| CD47 Antigen | 1 | 2017 | 26 | 0.040 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2017 | 71 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 1996 | 512 | 0.040 |
Why?
|
| Autopsy | 1 | 1997 | 173 | 0.040 |
Why?
|
| Glycolysis | 1 | 2020 | 519 | 0.040 |
Why?
|
| Hepatitis | 1 | 2018 | 93 | 0.040 |
Why?
|
| Ramipril | 1 | 2016 | 6 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 1997 | 284 | 0.040 |
Why?
|
| Immunization, Passive | 1 | 1997 | 172 | 0.040 |
Why?
|
| Renal Elimination | 1 | 2016 | 12 | 0.040 |
Why?
|
| Keratoconus | 1 | 1997 | 53 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 673 | 0.040 |
Why?
|
| DNA Repair | 1 | 2005 | 1872 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2003 | 1555 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2018 | 335 | 0.040 |
Why?
|
| Microscopy, Atomic Force | 1 | 2016 | 29 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 778 | 0.040 |
Why?
|
| Th2 Cells | 1 | 1997 | 257 | 0.040 |
Why?
|
| Struthioniformes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1998 | 699 | 0.030 |
Why?
|
| Protease Inhibitors | 3 | 2005 | 210 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 383 | 0.030 |
Why?
|
| Tropomyosin | 1 | 2015 | 38 | 0.030 |
Why?
|
| Organic Anion Transport Protein 1 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 978 | 0.030 |
Why?
|
| Aquaporin 1 | 1 | 2015 | 8 | 0.030 |
Why?
|
| Testis | 1 | 2000 | 717 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1997 | 275 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2010 | 3033 | 0.030 |
Why?
|
| Myosins | 1 | 2015 | 96 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 13658 | 0.030 |
Why?
|
| Tubulin | 1 | 2015 | 169 | 0.030 |
Why?
|
| Integrin alphaV | 1 | 2015 | 20 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1997 | 829 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2015 | 25 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 1997 | 446 | 0.030 |
Why?
|
| Chickens | 1 | 2015 | 523 | 0.030 |
Why?
|
| Transplantation, Heterotopic | 1 | 2015 | 43 | 0.030 |
Why?
|
| Genes | 2 | 2012 | 491 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 1077 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 684 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 1678 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2015 | 113 | 0.030 |
Why?
|
| Reference Values | 1 | 1997 | 1099 | 0.030 |
Why?
|
| G2 Phase | 1 | 2015 | 206 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 1230 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2002 | 1546 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 342 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1992 | 354 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2015 | 348 | 0.030 |
Why?
|
| Uroplakin II | 1 | 2014 | 15 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8223 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2002 | 2054 | 0.030 |
Why?
|
| Neurons | 1 | 2005 | 2287 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2011 | 5319 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 558 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2021 | 1154 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 528 | 0.030 |
Why?
|
| Child | 3 | 2008 | 29154 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2013 | 2074 | 0.030 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2003 | 23 | 0.030 |
Why?
|
| Placentation | 1 | 2013 | 60 | 0.030 |
Why?
|
| Point Mutation | 1 | 1996 | 769 | 0.030 |
Why?
|
| Urodynamics | 1 | 2013 | 57 | 0.030 |
Why?
|
| Urination | 1 | 2013 | 36 | 0.030 |
Why?
|
| Embryo Transfer | 1 | 2013 | 83 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 4320 | 0.030 |
Why?
|
| Cornea | 1 | 1997 | 638 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 79 | 0.030 |
Why?
|
| Captopril | 1 | 2012 | 34 | 0.030 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 421 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2012 | 19 | 0.030 |
Why?
|
| Actin Cytoskeleton | 1 | 2012 | 82 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2015 | 619 | 0.030 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2015 | 218 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 1991 | 135 | 0.030 |
Why?
|
| Isocoumarins | 2 | 2002 | 6 | 0.030 |
Why?
|
| Endoglin | 1 | 2011 | 43 | 0.030 |
Why?
|
| Adolescent | 5 | 2011 | 31252 | 0.030 |
Why?
|
| Peptide Library | 1 | 2012 | 158 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 1997 | 1029 | 0.020 |
Why?
|
| Retina | 1 | 2015 | 532 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 448 | 0.020 |
Why?
|
| Bowman Capsule | 1 | 2010 | 1 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 237 | 0.020 |
Why?
|
| Umbilical Veins | 2 | 2000 | 115 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 336 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 663 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 49 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 354 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2011 | 164 | 0.020 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2010 | 47 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2010 | 83 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 1053 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 196 | 0.020 |
Why?
|
| Complement C3 | 1 | 2010 | 78 | 0.020 |
Why?
|
| Pedigree | 2 | 2005 | 1890 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 14889 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 308 | 0.020 |
Why?
|
| Cystatin A | 1 | 2009 | 1 | 0.020 |
Why?
|
| Cystatin B | 1 | 2009 | 6 | 0.020 |
Why?
|
| Bone Demineralization Technique | 1 | 2009 | 2 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2010 | 227 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2009 | 43 | 0.020 |
Why?
|
| Bone Matrix | 1 | 2009 | 16 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2000 | 92 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2232 | 0.020 |
Why?
|
| Osteocytes | 1 | 2009 | 27 | 0.020 |
Why?
|
| Antibody Affinity | 2 | 2000 | 61 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1994 | 1681 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2009 | 80 | 0.020 |
Why?
|
| Elastin | 1 | 2009 | 49 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 368 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2001 | 355 | 0.020 |
Why?
|
| Goals | 1 | 2010 | 185 | 0.020 |
Why?
|
| Gelatinases | 2 | 1999 | 52 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2001 | 151 | 0.020 |
Why?
|
| Birds | 1 | 2009 | 92 | 0.020 |
Why?
|
| Phenylalanine | 2 | 1999 | 142 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 4744 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2010 | 333 | 0.020 |
Why?
|
| Thiophenes | 2 | 1999 | 148 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2007 | 107 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2015 | 908 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 626 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2010 | 310 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2007 | 80 | 0.020 |
Why?
|
| Chromatin | 1 | 2012 | 942 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2009 | 477 | 0.020 |
Why?
|
| Chromatography, Affinity | 2 | 1997 | 122 | 0.020 |
Why?
|
| Carbon Tetrachloride Poisoning | 1 | 2006 | 13 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2007 | 91 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 435 | 0.020 |
Why?
|
| Cystatins | 1 | 2005 | 15 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1999 | 1165 | 0.020 |
Why?
|
| Microscopy, Polarization | 1 | 2005 | 9 | 0.020 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2005 | 33 | 0.020 |
Why?
|
| Hematoxylin | 1 | 2005 | 34 | 0.020 |
Why?
|
| Cystatin C | 1 | 2005 | 54 | 0.020 |
Why?
|
| TRPC6 Cation Channel | 1 | 2005 | 1 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2005 | 19 | 0.020 |
Why?
|
| TRPC Cation Channels | 1 | 2005 | 16 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 261 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2005 | 75 | 0.020 |
Why?
|
| DNA Ligase ATP | 1 | 2005 | 51 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 1129 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2005 | 234 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 190 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2006 | 557 | 0.020 |
Why?
|
| Tyrosine | 1 | 2006 | 498 | 0.020 |
Why?
|
| Integrin alpha3 | 1 | 2004 | 3 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 1491 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2000 | 5542 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2006 | 652 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 261 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2005 | 144 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 483 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2004 | 105 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 186 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2005 | 402 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2003 | 132 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1997 | 548 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 174 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 849 | 0.010 |
Why?
|
| Spleen | 1 | 2005 | 676 | 0.010 |
Why?
|
| Dioxoles | 1 | 2002 | 19 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2002 | 56 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 203 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2002 | 200 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 394 | 0.010 |
Why?
|
| Proline | 1 | 2002 | 130 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2002 | 149 | 0.010 |
Why?
|
| Procollagen | 1 | 2001 | 31 | 0.010 |
Why?
|
| Lisinopril | 1 | 2001 | 24 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2014 | 9244 | 0.010 |
Why?
|
| Glutamyl Aminopeptidase | 1 | 2001 | 4 | 0.010 |
Why?
|
| Sulfates | 1 | 2001 | 45 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 1618 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2001 | 84 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 1046 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2003 | 478 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 311 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2001 | 128 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 621 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2001 | 110 | 0.010 |
Why?
|
| Pichia | 1 | 2000 | 60 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 613 | 0.010 |
Why?
|
| Tetrazoles | 1 | 2001 | 106 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2002 | 263 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 827 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2000 | 182 | 0.010 |
Why?
|
| Vimentin | 1 | 2001 | 253 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 706 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 2000 | 75 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 1869 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 1163 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1999 | 74 | 0.010 |
Why?
|
| Receptors, Angiotensin | 1 | 1999 | 44 | 0.010 |
Why?
|
| Infant | 1 | 2015 | 13310 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 726 | 0.010 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 1999 | 25 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2002 | 582 | 0.010 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 1999 | 57 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 1999 | 80 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 3443 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 1999 | 46 | 0.010 |
Why?
|
| Heparin | 1 | 2001 | 360 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1999 | 249 | 0.010 |
Why?
|
| Cell Separation | 1 | 2000 | 612 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 2422 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1999 | 240 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1999 | 241 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1997 | 38 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2002 | 1944 | 0.010 |
Why?
|
| Solubility | 1 | 1997 | 242 | 0.010 |
Why?
|
| Adenoma, Oxyphilic | 1 | 1997 | 82 | 0.010 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 1996 | 11 | 0.010 |
Why?
|
| Hybridomas | 1 | 1997 | 75 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 73 | 0.010 |
Why?
|
| Staphylococcal Protein A | 1 | 1996 | 18 | 0.010 |
Why?
|
| Immunization | 1 | 1998 | 397 | 0.010 |
Why?
|
| Adsorption | 1 | 1996 | 46 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1996 | 42 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1996 | 198 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2006 | 2518 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 1996 | 61 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1997 | 173 | 0.010 |
Why?
|
| Ribosomal Proteins | 1 | 1996 | 118 | 0.010 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1995 | 23 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1999 | 703 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 999 | 0.010 |
Why?
|
| Paclitaxel | 1 | 2002 | 1996 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1996 | 869 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 1155 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1994 | 141 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1994 | 172 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1999 | 1459 | 0.010 |
Why?
|
| Gestational Age | 1 | 1996 | 1069 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 5377 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 21445 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 264 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 87 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1993 | 515 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 1991 | 208 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2000 | 8865 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1998 | 2638 | 0.000 |
Why?
|
| Esophageal Neoplasms | 1 | 2000 | 3168 | 0.000 |
Why?
|